AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors
Read more at MarketWatch
Topics
-
ServiceNow flirts with $200 billion market cap as AI momentum draws cheers
Business - MarketWatch - October 24 -
Waymo Raises $5.6 Billion From Outside Investors
Business - The New York Times - October 28 -
Musk's Tesla hits $1T market cap after Trump win
Politics - The Hill - November 8 -
Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug looms
Business - MarketWatch - October 24 -
Amgen says no concerns around weight loss drug’s bone density data after stock falls
Business - CNBC - November 13 -
Hoping for a weight-loss pill? It could get closer to reality next week.
Business - MarketWatch - November 2 -
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial
Business - MarketWatch - November 4
More from MarketWatch
-
Trump’s choice of TV’s ‘Dr. Oz’ to oversee Medicare and Medicaid could be ‘devastating’ for millions of Americans
Business - MarketWatch - 25 minutes ago -
Treasury yields slip as traders weigh increased Russia-Ukraine tensions
Business - MarketWatch - 29 minutes ago -
This Roth strategy lets elite savers stash $70,000 in their 401(k) in 2025
Business - MarketWatch - 32 minutes ago -
After Nvidia’s earnings, this is the most impressive feat
Business - MarketWatch - 34 minutes ago -
Retail investors are feeling unusually optimistic about the market — here’s why
Business - MarketWatch - 36 minutes ago